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single voxel. Test-retest measurements are a method to 
determine the smallest volume for which a reliable 
measurement can be obtained. A key asset of functional 
imaging is the capacity to measure physical quantities in 
tissue rather than contrast. In particular for longitudinal 
studies, monitoring treatment response, or in multi-center 
studies, this is critical. For radiotherapy dose painting it is 
necessary to know which threshold should be used to define a 
subvolume of the target for dose escalation. In the 
presentation, various quantitative methods and their 
reliability will be discussed. 
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Dynamic contrast-enhanced magnetic resonance imaging 
(DCE-MRI) is a technique based on rapid acquisition of a 
series of images depicting the uptake of a contrast agent (CA) 
in tissue. Through mathematical modeling of the CA’s 
influence on the MR signal and the distribution of CA in the 
tissue, physiological parameters can be obtained on a voxel 
by voxel level.  
These parameters, which for instance reflect flow, vessel 
integrity, cell and vessel density, are highly relevant in 
cancer treatments such as radiotherapy (RT). Several studies 
have shown that pretreatment parameter values as well as 
changes during RT can be correlated with outcome. However, 
drawing firm conclusions on the practical value of DCE-MRI in 
RT is currently difficult.  
The reason for this difficulty has its roots in the complexity 
of performing a DCE-MRI study. Obtaining accurate 
quantitative parameter values reflecting primarily the 
physiology of a tumor requires advanced imaging as well as 
complicated post processing. Unfortunately, even though 
state of the art acquisition and analysis is performed it is 
likely that influences from the precise acquisition settings 
and the analysis tools remain in the final result. Hence it is 
crucial that all variations during a study is minimized to 
maximize the sensitivity.  
Not only is it of great importance to reduce the variability 
within a study, ideally this should also be the case between 
studies. But here we have a significant issue. There are a 
large number of unavoidable trade-offs in DCE-MRI. For 
instance between spatial and temporal resolution and 
between accuracy, complexity and robustness of the analysis. 
Usually each group performing a study make their own 
decision on where to compromise and what parameters to 
evaluate. Although this may be optimal in each study it is 
problematic when drawing conclusions on the overall value of 
DCE-MRI in RT.  
Of this reason several authors are calling for standardization 
of DCE-MRI acquisition and analysis. One organization that 
has responded to this call is the Quantitative Imaging 
Biomarkers Alliance (QIBA) which has published guidelines for 
standardizing DCE-MRI. In a comparison of methodology in 
studies employing DCE-MRI in RT the results are mixed. 
Overall, the technical quality of studies, measured as 
compliance with QIBA guidelines, is improving with time. 
However, the spread is also increasing. Hopefully, in the 
future more people will adhere to the attempts to 
standardize DCE-MRI and thus enable more homogenous data 
which can be used for better answering how DCE-MRI can be 
employed to improve RT. 
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Over the last decade, Diffusion Weighted MRI(DWI) has 
emerged as a promising imaging technique in the field of 
radiation oncology.  
The ability of DWI to assess a tissue's microstructure makes it 
potentially very valuable in tumor characterization, 
delineation, detection of pathological lymph nodes, response 
prediction and response evaluation.  
However, acquisition, analysis and interpretation of the 
images is far from straightforward. The imaging technique is 
prone to distortions interfering with the accurate geometrical 
localisation and quantification of the tissue of interest. 
Furthermore quantification is heavily influenced by the 
choice of machine parameters, making reproducibility an 
important issue.  
Overcoming these problems is of the utmost importance to 
move DWI out of the realm of research and into daily 
practice.  
In this talk we will identify the important parameters 
influencing acquisition and quantification of DWI, with 
emphasis on the choice of b-values and geometrical 
accuracy. We will discuss the implications when using DWI for 
extracranial radiotherapy. Finally we will look into possible 
solutions and provide a framework to ensure maximal 
exploitation of the imaging technique for the future.  
 
Joint Symposium: ESTRO-IAEA: Joint ESTRO-IAEA efforts on 
dosimetry, QA and audit for advanced treatment 
techniques  
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Increased use of small photon fields in stereotactic and 
intensity modulated radiotherapy has raised the need for 
standardizing the dosimetry of such fields using procedures 
consistent with those for conventional radiotherapy. While 
many problems of small field dosimetry have been raised in 
the past, e.g. in Report 103 of the Institute of Physics and 
Engineering in Medicine, a vast amount of literature has 
addressed most of those and solutions have been proposed 
for specific situations. What has hampered the development 
of a Code of Practice until recently was the availability of 
data but in the last few years a considerable number of 
publications have provided new data and insights that have 
enhanced our understanding of small field dosimetry. 
An international working group, established by the 
International Atomic Energy Agency (IAEA) in collaboration 
with the American Association of Physicists in Medicine 
(AAPM), has finalised a Code of Practice for the dosimetry of 
small static photon fields. The Code of Practice consists of six 
chapters and two appendices. The first chapter provides an 
introduction to situate the distinct role of this Code of 
Practice as compared to previous recommendations for 
reference dosimetry in external beam radiotherapy. The 
second chapter provides a brief discussion of the physics of 
small photon fields with emphasis on those aspects that are 
relevant to understanding the concepts of the Code of 
Practice. Particular issues that are addressed are the 
definition of field size, the field size dependent response of 
detectors, volume averaging, fluence perturbation 
corrections, reference conditions and beam quality in non-
conventional reference fields. The third chapter introduces 
all details of the formalism used, which is based on the IAEA-
AAPM formalism published by Alfonso et al. (Med Phys 
35:5179-5186, 2008) and is extended to clarify its application 
to flattening-filter-free beams (FFF beams). The fourth 
chapter provides a comprehensive overview of suitable 
dosimeters for reference dosimetry in the conventional 10 cm 
x 10 cm reference fields, for reference dosimetry in machine-
specific reference fields at machines that cannot establish a 
conventional 10 cm x 10 cm reference field and for the 
determination of field output factors in small fields. The fifth 
chapter gives practical recommendations for implementing 
reference dosimetry in both conventional 10 cm x 10 cm 
ESTRO 35 2016                                                                                                                                                    S11 
______________________________________________________________________________________________________ 
reference fields and machine-specific reference fields. The 
sixth chapter provides the practical recommendations for the 
determination of field output factors in small photon fields. 
Comprehensive data on beam quality correction factors for 
ionization chamber types recommended for reference 
dosimetry are provided in chapter five and a detailed 
discussion on how they have been derived from the literature 
as well as a discussion of their uncertainties is given in the 
first Appendix. For beams with flattening filter (WFF beams) 
these data are consistent with the ones given in IAEA TRS-398 
and the update to AAPM TG-51. For FFF beams additional 
corrections are taken into account for the difference in water 
to air stopping power ratios between FFF and WFF beams and 
for volume averaging due to the non-uniform lateral beam 
profiles. Comprehensive data on small field correction factors 
are given in chapter six for a wide range of recommended 
small field detectors. The second Appendix discusses in detail 
how these data have been compiled from the literature 
including both Monte Carlo calculated and experimental data 
and also provides a thorough evaluation of the uncertainties 
of those data. 
The Code of Practice has been reviewed by referees selected 
by the AAPM and by the IAEA and is currently submitted for 
publication by the IAEA. This presentation is given on behalf 
of the IAEA-AAPM Working Group on small and non-standard 
field dosimetry. 
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During the last years small field dosimetry (re-)gained 
importance. Several working groups highlighted its relevance 
in the context of high precision radiotherapy techniques. 
Non-conventional linear accelerators that do not support 
standard reference geometry and the upcoming unflattened 
photon beams had an impact on upcoming recommendations 
in this context as well. However, recent audits revealed large 
uncertainties in small field dosimetry with deviations up to 
10% for 2 x 2 cm2 fields, which motivated the present 
contribution. Clinically used beam models of two TPS 
(Monaco, ELEKTA and iPlan, BrainLAB) were modified to 
mimic the large uncertainties in small field output factors. 
Next IMRT and VMAT treatment plans for prostate and head 
and neck cancer cases as well as treatment plans for 
stereotactic brain lesions were generated and calculated with 
correct and incorrect beam models, respectively. Finally, 
treatment plans were delivered with an ELEKTA Versa HD 
linac. Dose calculations were compared with measurements 
performed with EBT films and a detector array. Effects of 
uncertainties in small field output factors were less 
pronounced for IMRT and VMAT plans compared to 
stereotactic techniques delivered with static fields or 
dynamic arcs. TPS specific sequencing of IMRT and VMAT had 
an impact on the final results. The gamma evaluation 
performed with detector arrays was not able to dissolve 
uncertainties in small field dosimetry due to the rather large 
detector. On the other hand single detector signal was 
sensitive to such uncertainties. Upcoming treatment 
techniques like dose painting will use small fields more 
extensively and motivates highest accuracy in small field 
dosimetry. Published reference data and guidelines including 
detector correction factors contribute to eliminate gross 
uncertainties (>5%) in small field dosimetry. 
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The postal dose audit programme for radiotherapy dosimetry 
operated jointly by the International Atomic Energy Agency 
(IAEA) and the World Health Organization (WHO) has been in 
existence for over 45 years. To-date the calibration of over 
11300 radiotherapy beams in 2200 hospitals in 132 countries 
has been audited. Several hospitals have improved their 
dosimetry practices over the years, and the percentage of 
acceptable results is > 95% at present. The IAEA records 
suggest that regular participation in audits is associated with 
higher quality dosimetry than the first participation. It 
confirms that the dosimetry audit is useful to enhance 
confidence in radiotherapy dosimetry for both medical 
physicists and clinicians who need assurance that their 
patients receive safe and high quality radiation treatment, 
which is not possible without accurate dosimetry. However, 
with the increasing complexity of radiotherapy treatments, 
basic dosimetry audits are no longer sufficient and more 
complex audit programmes testing different dosimetry 
parameters and treatment delivery techniques are required.  
The first IAEA ‘end-to-end’ audit methodology was developed 
for 3D conformal radiotherapy. It reviewed dosimetry, 
imaging, treatment planning and radiotherapy delivery 
processes following the pathway similar to that of the patient 
undergoing radiotherapy. The audit was implemented at 
national levels with the IAEA providing an anthropomorphic 
thorax phantom (CIRS) and expert advice. National groups 
conducted the audit at local hospitals through on-site visits. 
TPS calculated doses were compared with ion chamber 
measurements for a set of test cases. In Europe, the audit 
has been carried out in 60 hospitals in 8 countries. About 200 
data sets have been collected and reviewed. Discrepancies 
requiring interventions were discovered in about 10% of 
datasets. In addition, suboptimal beam modelling in TPSs 
occurred in several centres. Overall, the audit contributed to 
better understanding of the performance of TPSs and helped 
to resolve discrepancies related to imaging, dosimetry and 
treatment planning.  
Recently, a new methodology has been developed for on-site 
‘end-to-end’ audits to review the physics aspects of head and 
neck IMRT treatments. It uses a dedicated anthropomorphic 
head and shoulders phantom (CIRS) with a set of contours 
representing the target volumes and organs at risk. The 
contours are imported and superimposed on the CT scans of 
the phantom. The treatment plan is developed and 
transferred to the treatment machine for the dose delivery. 
Ion chambers and radiochromic films are used for dose 
measurements. Comparisons are made between the TPS 
calculated and measured doses. The audit methodology is 
currently tested within an international study group.  
For >20 years the IAEA has supported the development of 
audit methodologies for national audit groups using remote 
audit tools. Current projects focus on remote IMRT audits 
involving different audit steps, e.g. small beam dosimetry 
relevant for IMRT. One study compared TPS calculated beam 
outputs to the published reference data sets. The results 
showed good agreement (within 1%) between the TPS output 
and the reference data for field sizes ≥ 4×4 cm2 and dose 
overestimation by TPSs by 2%−3% for field sizes ≤ 3×3 cm2. 
Auditing methodology was also developed to verify the TPS 
modelling of small MLC shaped beam profiles using 
radiochromic film measurements for 2×5 cm2 and a 2×2 cm2 
fields. Relative differences between the profiles at 20%, 50% 
and 80% dose levels were evaluated. Only 64% beam profiles 
were within 3 mm agreement between the TPS calculated 
and film measured doses. This highlights some limitations in 
TPS modelling of small beam profiles in the direction of MLC 
leave movements. Such differences can affect patient 
treatments, especially for stereotactic radiotherapy and 
IMRT. Another study evaluated MLC performance using picket 
fence tests and confirmed that most MLCs performed as 
expected. A comparison of gamma analysis techniques was 
also conducted through a multicentre analysis of a film 
irradiated with a complex field arrangement. Differences in 
gamma agreement occurred that were attributed to the 
differences in film scanning parameters and gamma 
calculation algorithms. A newest study on remote ‘end-to-
end’ IMRT audit is on-going. Overall, the results of these 
studies demonstrate challenges in TPS commissioning for 
